Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-08-06 11:43 am Purchase |
2020-07-22 | 13G | Acer Therapeutics Inc. ACER |
Orin Hirschman | 982,446 11.000% |
430,406 (+77.97%) |
Filing History |
| 2020-07-21 5:17 pm Purchase |
2020-07-21 | 13G | TETRA Technologies, Inc. TTI |
Orin Hirschman | 6,757,729 5.370% |
6,757,729 (New Position) |
Filing History |
| 2020-07-21 08:03 am Purchase |
2020-07-10 | 13G | Annovis Bio, Inc. ANVS |
Orin Hirschman | 498,797 7.270% |
175,507 (+54.29%) |
Filing History |
| 2020-07-10 4:20 pm Sale |
2020-07-07 | 13G | Annovis Bio, Inc. ANVS |
Orin Hirschman | 323,290 4.740% |
-191,710 (-37.23%) |
Filing History |
| 2020-07-10 4:18 pm Sale |
2020-06-30 | 13G | RF Industries, Ltd. RFIL |
Orin Hirschman | 406,115 4.370% |
-144,485 (-26.24%) |
Filing History |
| 2020-07-10 4:15 pm Sale |
2020-06-30 | 13G | Cellectar Biosciences, Inc. CLRB |
Orin Hirschman | 103,423 4.310% |
-53,097 (-33.92%) |
Filing History |
| 2020-07-07 09:53 am Purchase |
2020-06-26 | 13G | Ocean Bio-Chem, Inc. OBCI |
Orin Hirschman | 718,556 7.600% |
718,556 (New Position) |
Filing History |